Indications
Therapeutic Asset Ratings
18,134 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Sirolimus
Myelofibrosis
Masonic Cancer Center, University of Minnesota
P2
BB
(65)
Sirolimus
Myeloid Leukemia
Masonic Cancer Center, University of Minnesota
P2
BB
(65)
Tacrolimus
Hematopoietic And Lymphoid Cell Neoplasm
Fred Hutchinson Cancer Center
P2
BB
(65)
Thiotepa
Immunodeficiency Disease
University of California, San Francisco
P2
BB
(65)
Venetoclax
Breast Cancer
Dana-Farber Cancer Institute
P2
BB
(65)
Venetoclax
Burkitt Lymphoma
Children's Hospital Medical Center, Cincinnati
P2
BB
(65)
Venetoclax
Hematopoietic And Lymphoid Cell Neoplasm
University of Alabama at Birmingham
P2
BB
(65)
Venetoclax
Myeloid Sarcoma
Ruijin Hospital
P2
BB
(65)
(+)-Vincristine
Childhood Malignant Neoplasm
Tianjin Medical University Cancer Institute and Hospital
P2
BB
(65)
(+)-Vincristine
Myelodysplastic Syndrome
Andrew E. Place, MD
P2
BB
(65)
(+)-Vincristine
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P2
BB
(65)
XENON
Non-Small Cell Lung Carcinoma
Xemed LLC
P2
BB
(65)
Apsolol
Intracerebral Hemorrhage
Tang-Du Hospital
P2/3
BB
(65)
Busulfanum
Primary Central Nervous System Lymphoma
Sichuan University
P2/3
BB
(65)
Busulfanum
Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2/3
BB
(65)
Busulfanum
Severe Combined Immunodeficiency
National Institute of Allergy and Infectious Diseases (NIAID)
P2/3
BB
(65)
Cyclophosphamide
Acquired Idiopathic Inflammatory Myopathy
Tongji Hospital
P2/3
BB
(65)
Cyclophosphamide
Interstitial Lung Disease
Intergroupe Francophone de Cancerologie Thoracique
P2/3
BB
(65)
Cyclophosphamide
Severe Combined Immunodeficiency
St. Jude Children's Research Hospital
P2/3
BB
(65)
Dianhydrogalactitol
Glioblastoma
Global Coalition for Adaptive Research
P2/3
BB
(65)
Diphenhydramine
Breast Carcinoma
Ohio State University Comprehensive Cancer Center
P2/3
BB
(65)
Fludarabine
Precursor B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P2/3
BB
(65)
Indocyanine Green
Neoplasm
University of Pennsylvania
P1/2
BB
(65)
Linperlisib
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Ruijin Hospital
P2/3
BB
(65)
Piflufolastat
Prostate Neoplasm
Novartis Pharmaceuticals
P2/3
BB
(65)
Showing 4026 to 4050 of 18,134 assets
Previous
Page 162 of 726
Next